What question did this study set out to answer?

The research aims to understand the variability of ATNIVS biomarker profiles in patients treated with lecanemab.

April 15, 2026Open Access

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab

The research aims to understand the variability of ATNIVS biomarker profiles in patients treated with lecanemab.
Assessment of ATNIVS biomarker profiles
Evaluation in a real-world patient setting
Qualitative analysis of biomarker heterogeneity
Substantial variability in ATNIVS biomarker profiles found
Implications for personalized treatment approaches
Data highlights the complexity of patient responses to lecanemab

We identified substantial heterogeneity in ATNIVS biomarker profiles among patients receiving lecanemab in a real-world setting.

Building similarity graph...

Analyzing shared references across papers

Masanori Kurihara

Ryoko Ihara

Gen Yoshii

The Journal of Prevention of Alzheimer s Disease

Nagasaki University

Tokyo Metropolitan Institute of Gerontology

Cognitive Neuroimaging Lab

Building similarity graph...

Analyzing shared references across papers